HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insulin sensitizers improve the GLP-1 secretion and the amount of intestinal L cells on high-fat-diet-induced catch-up growth.

AbstractOBJECTIVE:
The aim of this study was to investigate whether insulin resistance can result in impaired glucagon-like peptide (GLP)-1 secretion and to determine whether insulin-sensitizing drugs could improve the secretion of GLP-1 in catch-up growth rats.
METHODS:
Male Sprague Dawley rats were used to establish a catch-up growth model. At the end of weeks 6 and 14, these rats were euthanized to measure energy intake, body weight, plasma triacylglycerol, and nonesterified fatty acid. Fat mass percentage was analyzed by dual-energy x-ray absorptiometry scan. The GLP-1 concentrations were measured by enzyme-linked immunosorbent assay, the glucose infusion rates were measured by hyperinsulinemic-glucose clamp experiment. Quantification of the GLP-1 positive cells in distal ileum was done by immunohistochemical staining method. The L cell line NCI-H716 cells were treated in vitro with palmitate acid, the cells' viability, the carnitine palmitoyl transferase-1, and the insulin signaling pathway were detected.
RESULTS:
Rats fed a high-fat diet rats had rapidly developed insulin resistance, impaired incretin effect, and a reduction in the number of intestinal L cells. The insulin sensitizers, metformin and pioglitazone, improved insulin resistance and the concentration of circulating GLP-1, increased the relative number of intestinal L cells to a certain degree. In vitro, the NCI-H716 cell viability was decreased and impaired insulin signaling pathway with palmitate acid treatment, metformin treatment could reverse these effects, whereas pioglitazone could not.
CONCLUSIONS:
Insulin resistance caused by a high-fat diet could result in reduced GLP-1 secretion; the insulin sensitizing drugs were able to improve the incretin effect in catch-up growth rats.
AuthorsJuan Zheng, Kang-Li Xiao, Lulu Chen, Chaodong Wu, Xiang Hu, Tianshu Zeng, Xiao-Qian Chen, Wen-Juan Li, Xiuling Deng, Huiqing Li, Yu-Ming Li
JournalNutrition (Burbank, Los Angeles County, Calif.) (Nutrition) 2017 Jul - Aug Vol. 39-40 Pg. 82-91 ISSN: 1873-1244 [Electronic] United States
PMID28606576 (Publication Type: Journal Article)
CopyrightCopyright © 2017. Published by Elsevier Inc.
Chemical References
  • Hypoglycemic Agents
  • Incretins
  • Thiazolidinediones
  • Glucagon-Like Peptide 1
  • Metformin
  • Pioglitazone
Topics
  • Absorptiometry, Photon
  • Animals
  • Diet, High-Fat
  • Enteroendocrine Cells (drug effects, metabolism)
  • Enzyme-Linked Immunosorbent Assay
  • Glucagon-Like Peptide 1 (drug effects, metabolism)
  • Hypoglycemic Agents (pharmacology)
  • Incretins (metabolism)
  • Insulin Resistance
  • Male
  • Metformin (pharmacology)
  • Models, Animal
  • Pioglitazone
  • Rats
  • Rats, Sprague-Dawley
  • Thiazolidinediones (pharmacology)
  • Weight Gain (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: